Tildrakizumab Efficacy on Psoriasis in Patients with Psoriatic Arthritis-An Analysis from a Phase 2 Study

被引:0
|
作者
Gottlieb, Alice [1 ]
Orbai, Ana-Maria [2 ]
Ballerini, Rocco [3 ]
Chou, Richard C. [4 ]
Rozzo, Stephen [3 ]
Mendelsohn, Alan [3 ]
Espinoza, Luis R. [5 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA
[2] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA
[3] Sun Pharmaceut Ind Inc, Princeton, NJ USA
[4] SUNY Buffalo, Sch Med & Biomed Sci, Buffalo, NY USA
[5] LSU Hlth Sci Ctr, Sect Rheumatol, New Orleans, LA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1524
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Tildrakizumab efficacy on psoriasis in patients with psoriatic arthritis-an analysis from a phase 2 study
    Gottlieb, A. B.
    Ballerini, R.
    Chou, R. C.
    Rozzo, S. J.
    Rozzo, S.
    Espinoza, L. R.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 44 - 44
  • [2] TILDRAKIZUMAB EFFICACY ON PSORIASIS IN PATIENTS WITH PSORIATIC ARTHRITIS-A 52-WEEK ANALYSIS FROM A PHASE 2 STUDY
    Gottlieb, A. B.
    Ritchlin, C. T.
    Chou, R. C.
    Mendelsohn, A. M.
    Rozzo, S.
    Espinoza, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1157 - 1158
  • [3] The effect of guselkumab on psoriasis in patients with active psoriatic arthritis: Results from a phase 2 study
    Gottlieb, A. B.
    Boehncke, W-H.
    Helliwell, P.
    Deodhar, A.
    Xu, X. L.
    Xu, S.
    Wang, Y.
    Zhuang, Y.
    Hsia, E. C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB131 - AB131
  • [4] The effect of guselkumab on psoriasis in patients with active psoriatic arthritis: results from a phase 2 study
    Gottlieb, A. B.
    Wolf-Henning, B.
    Helliwell, P.
    Deodhar, A.
    Ozturk, B.
    Xu, X. L.
    Xu, S.
    Wang, Y.
    Zhuang, Y.
    Hsia, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 36 - 37
  • [5] Tildrakizumab Efficacy and Safety in Patients with Psoriatic Arthritis by Metabolic Syndrome Status
    Kavanaugh, Arthur
    Raychaudhuri, Siba
    Ritchlin, Christopher
    Asahina, Akihiko
    Rahman, Proton
    Murphy, Fred
    Rozzo, Stephen
    Yao, Siu-Long
    Chou, Richard C.
    Husni, Elaine
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3795 - 3797
  • [6] Tildrakizumab efficacy and safety in patients with psoriatic arthritis by metabolic syndrome status
    Kavanaugh, Arthur
    Raychaudhuri, Siba
    Ritchlin, Christopher
    Asahina, Akihiko
    Rahman, Proton
    Murphy, Fred
    Rozzo, Stephen J.
    Yao, Siu-Long
    Chou, Richard
    Husni, M. Elaine
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 7 - 8
  • [7] Efficacy and safety of etanercept in psoriasis and psoriatic arthritis in the PRESTA study: analysis in patients from Central and Eastern Europe
    Damjanov, Nemanja
    Karpati, Sarolta
    Kemeny, Lajos
    Bakos, Noemi
    Bobic, Branislav
    Majdan, Maria
    Tlustochowicz, Witold
    Vitek, Petr
    Dokoupilova, Eva
    Aldinc, Emre
    Szumski, Annette
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (01) : 8 - 12
  • [8] Tildrakizumab: Successful Response in Two Patients With Psoriatic Arthritis
    Buononato, Dario
    Licata, Gaetano
    Gambardella, Alessio
    De Rosa, Alina
    Calabrese, Giulia
    Argenziano, Giuseppe
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2022, 12 (02):
  • [9] Real-World Data From the Joint Psoriasis-Psoriatic Arthritis Clinic (PPAC) on the Efficacy of Bimekizumab in Patients With Psoriasis and Psoriatic Arthritis
    Vaiopoulos, Aristeidis G.
    Michelakis, Ioannis
    Katsimbri, Pelagia
    Lampadaki, Kyriaki
    Katsifis, Dimitrios
    Sabatakaki, Elena
    Tseronis, Dimitrios
    Zoupidou, Konstantina
    Katoulis, Alexander
    Papadavid, Evangelia
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2025,
  • [10] Deucravacitinib efficacy in psoriatic arthritis by baseline DMARD use: Exploratory analysis from a phase 2 study
    Deodhar, Atul
    Nowak, Miroslawa
    Ye, June
    Lehman, Tom
    Wei, Lan
    Banerjee, Subhashis
    Mease, Philip J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB156 - AB156